Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Zonta

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Antiviral Chemistry & Chemotherapy|March 17, 2010
Advanced in silico approaches in antiviral researchNicola Zonta, Antonio Coluccia, Andrea Brancale
Journal of Molecular Modeling|December 3, 2008
Accessible haptic technology for drug design applicationsNicola Zonta, Ian J Grimstead, Nick J Avis, et al.
Journal of Medicinal Chemistry|December 7, 2007
Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidinesMarco D Migliore, Nicola Zonta, Christopher McGuigan, et al.
Antiviral Research|February 6, 2013
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virusMarcella Bassetto, Tine De Burghgraeve, Leen Delang, et al.
Bioorganic & Medicinal Chemistry|September 9, 2009
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerizationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Bioorganic & Medicinal Chemistry|April 29, 2008
Design, synthesis, and biological evaluation of thiophene analogues of chalconesRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virusChristopher McGuigan, Karolina Madela, Mohamed Aljarah, et al.
Journal of Medicinal Chemistry|February 12, 2008
Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitorsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Antiviral Chemistry & Chemotherapy|March 17, 2010
Advanced in silico approaches in antiviral researchNicola Zonta, Antonio Coluccia, Andrea Brancale
Journal of Molecular Modeling|December 3, 2008
Accessible haptic technology for drug design applicationsNicola Zonta, Ian J Grimstead, Nick J Avis, et al.
Journal of Medicinal Chemistry|December 7, 2007
Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidinesMarco D Migliore, Nicola Zonta, Christopher McGuigan, et al.
Antiviral Research|February 6, 2013
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virusMarcella Bassetto, Tine De Burghgraeve, Leen Delang, et al.
Bioorganic & Medicinal Chemistry|September 9, 2009
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerizationRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Bioorganic & Medicinal Chemistry|April 29, 2008
Design, synthesis, and biological evaluation of thiophene analogues of chalconesRomeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2010
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virusChristopher McGuigan, Karolina Madela, Mohamed Aljarah, et al.
Journal of Medicinal Chemistry|February 12, 2008
Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitorsRomeo Romagnoli, Pier Giovanni Baraldi, Taradas Sarkar, et al.
Pageof 1